4 February 2016 - Deborah Wilkes
Archived
Worldwide sales by Pfizer's Consumer Healthcare business increased by 4% on an operational basis in the fourth quarter of 2015 "primarily due to Nexium 24HR in the US".
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.